• A Valet 20 mg (Avatrombopag): Treatment for Liver Disease Quick View
    • A Valet 20 mg (Avatrombopag): Treatment for Liver Disease Quick View
    • ,
    • A Valet 20 mg (Avatrombopag): Treatment for Liver Disease

    • Avalet 20 mg (Avatrombopag) is a revolutionary oral medication designed to treat thrombocytopenia (low platelet count) in adults with chronic liver disease (CLD) who are scheduled to undergo medical or dental procedures. Avatrombopag, the active ingredient in Avalet, is a thrombopoietin receptor agonist that stimulates platelet production in the bone marrow, helping to increase platelet counts and reduce the risk…
    • Read more
  • Abeclib | 150mg | (Abemaciclib) Quick View
    • Abeclib | 150mg | (Abemaciclib) Quick View
    • ,
    • Abeclib | 150mg | (Abemaciclib)

    • Abeclib 150mg is a potent therapeutic solution designed to target specific health conditions with precision. This detailed guide provides essential information about the medication, including its indications, pharmacology, dosage, interactions, side effects, and more. Whether you are a healthcare professional or a patient seeking clarity, this post offers the insights you need.
    • Read more
  • Acalabrutinib (Acaluxen 100mg): Blood Cancer therapy Quick View
    • Acalabrutinib (Acaluxen 100mg): Blood Cancer therapy Quick View
    • ,
    • Acalabrutinib (Acaluxen 100mg): Blood Cancer therapy

    • Acalabrutinib, marketed under the brand name Acaluxen 100mg, is a breakthrough medication used in the treatment of specific Blood Cancer therapy, including mantle cell lymphoma (MCL) and chronic lymphocytic leukaemia (CLL). As a second-generation Bruton’s tyrosine kinase (BTK) inhibitor, Acalabrutinib works by blocking the activity of BTK, a protein that contributes to the growth and survival of cancer cells. This…
    • Read more
  • Afanix 40 Mg (Afatinib) | Medication Of Lung Cancer​ Quick View
    • Afanix 40 Mg (Afatinib) | Medication Of Lung Cancer​ Quick View
    • ,
    • Afanix 40 Mg (Afatinib) | Medication Of Lung Cancer​

    • Afanix 40 Mg, containing the active ingredient Afatinib, is a powerful medication used in the treatment of non-small cell lung cancer (NSCLC). It belongs to the group of medications known as tyrosine kinase inhibitors (TKIs) that target and block specific proteins responsible for cancer cell growth. This makes Afanix 40 Mg an essential treatment option for patients with Medication Of…
    • Read more
  • Alecnib | 150 Mg | (Alectinib) Quick View
    • Alecnib | 150 Mg | (Alectinib) Quick View
    • Alecnib | 150 Mg | (Alectinib)

    • Alecnib 150mg (Alectinib) is an important medication used in the treatment of certain types of cancer, specifically non-small cell lung cancer (NSCLC) that is ALK-positive. It works by targeting and inhibiting the ALK (anaplastic lymphoma kinase) protein, which is responsible for the growth of cancer cells. In this blog post, we will explore Alecnib’s indications, pharmacology, dosage, interactions, side effects,…
    • Read more
  • Axinix (Axitinib 1mg / 5mg) Quick View
    • Axinix (Axitinib 1mg / 5mg) Quick View
    • Axinix (Axitinib 1mg / 5mg)

    • Axinix, the branded form of Axitinib, is a highly potent tyrosine kinase inhibitor (TKI) widely utilized in oncology. This blog provides an in-depth examination of Axinix (Axitinib) to offer valuable insights into its usage, mechanism, administration, and safety considerations.
    • Read more
  • Axinix 5 mg (Axitinib): Metastatic renal Cell Carcinoma Quick View
    • Axinix 5 mg (Axitinib): Metastatic renal Cell Carcinoma Quick View
    • Axinix 5 mg (Axitinib): Metastatic renal Cell Carcinoma

    •  Axinix 5 mg  contains  Axitinib , a potent oral medication specifically developed to treat advanced renal cell carcinoma (RCC) , a type of kidney cancer. Axitinib belongs to the class of drugs known as tyrosine kinase inhibitors (TKIs), which work by blocking the proteins that encourage cancer cells to grow and spread. Axinix is often used in cases where other…
    • Read more
  • Baricinix 4 mg Quick View
    • Baricinix 4 mg Quick View
    • Baricinix 4 mg

    • Baricinix 4 mg (baricitinib) is a powerful oral medication designed to treat moderate to severe rheumatoid arthritis (RA) in adults who have not responded well to other treatments. Baricitinib, the active ingredient in Baricinix, is a Janus kinase (JAK) inhibitor, which reduces inflammation and prevents the immune system from attacking the joints. Additionally, Baricinix 4 mg has been approved for…
    • Read more
  • Baricinix 4mg and 2mg (Baricitinib)Baricinix 4mg and 2mg (Baricitinib) Quick View
    • Baricinix 4mg and 2mg (Baricitinib)Baricinix 4mg and 2mg (Baricitinib) Quick View
    • Baricinix 4mg and 2mg (Baricitinib)

    • Baricinix- 4mg/2mg to Uses, Dosage, Side Effects, and More Baricinix, available in strengths of 4mg and 2mg, is an essential medication used to manage various medical conditions. This blog post provides a detailed overview of the medication, including its indications, pharmacology, dosage and administration, interactions, side effects, and much more. Read on to understand why Baricinix is trusted by healthcare…
    • Read more
  • Barigen 4Mg/2Mg (Baricitinib)Barigen 4Mg/2Mg (Baricitinib) Quick View
    • Barigen 4Mg/2Mg (Baricitinib)Barigen 4Mg/2Mg (Baricitinib) Quick View
    • ,
    • Barigen 4Mg/2Mg (Baricitinib)

    • Barigen-4mg/2mg is a well-known pharmaceutical product designed to provide effective treatment for a variety of medical conditions. This medication, available in both 4mg and 2mg doses, is commonly prescribed by healthcare professionals to manage specific conditions. In this post, we’ll provide a detailed overview of Barigen-4mg/2mg, covering its indications, pharmacology, dosage and administration, interactions, side effects, and much more.
    • Read more
  • Barinib 2 mg (Baricitinib) Quick View
    • Barinib 2 mg (Baricitinib) Quick View
    • Barinib 2 mg (Baricitinib)

    • Barinib 2 mg (baricitinib) is an innovative oral medication designed to treat moderate to severe rheumatoid arthritis (RA) in adults who have not responded well to other treatments. The active ingredient, Baricitinib, is a Janus kinase (JAK) inhibitor that helps reduce inflammation by targeting specific enzymes responsible for the overactive immune response in rheumatoid arthritis. Barinib 2 mg offers an…
    • Read more
  • Briganix 180 mg (Brigatinib): ALK Positive Lung Cancer Quick View
    • Briganix 180 mg (Brigatinib): ALK Positive Lung Cancer Quick View
    • Briganix 180 mg (Brigatinib): ALK Positive Lung Cancer

    • Briganix 180 mg (Brigatinib) is a cutting-edge oral medication designed to treat ALK-positive non-small cell lung cancer (NSCLC) in adults. Brigatinib is a next-generation tyrosine kinase inhibitor (TKI) that targets the abnormal anaplastic lymphoma kinase (ALK) gene mutation, a key driver of cancer cell growth in ALK-positive lung cancer. This medication is particularly effective for patients whose cancer has progressed…
    • Read more
  • Briganix 90 mg (Brigatinib): ALK Positive Lung Cancer Quick View
    • Briganix 90 mg (Brigatinib): ALK Positive Lung Cancer Quick View
    • Briganix 90 mg (Brigatinib): ALK Positive Lung Cancer

    • Briganix 90 mg (Brigatinib) is an advanced oral medication specifically designed for the treatment of ALK-positive non-small cell lung cancer (NSCLC) in adults. Brigatinib is a next-generation tyrosine kinase inhibitor (TKI) that targets the abnormal anaplastic lymphoma kinase (ALK) gene mutation, a key driver of cancer cell growth in some forms of lung cancer. Briganix 90 mg is especially effective…
    • Read more
  • Caboxen 20mgCaboxen 20mg Quick View
    • Caboxen 20mgCaboxen 20mg Quick View
    • Caboxen 20mg

    • Caboxen-20mg is a widely prescribed medication used to manage various medical conditions. It plays an important role in treating a number of ailments, thanks to its effectiveness and minimal side effects. In this comprehensive guide, we’ll cover everything you need to know about Caboxen-20mg, including its indications, pharmacology, dosage recommendations, interactions, side effects, and much more. Let’s dive into this…
    • Read more
  • Cabozanix (Cabozantinib 20,60,80mg):Targeted Therapy for CancerCabozanix (Cabozantinib 20,60,80mg):Targeted Therapy for Cancer Quick View
    • Cabozanix (Cabozantinib 20,60,80mg):Targeted Therapy for CancerCabozanix (Cabozantinib 20,60,80mg):Targeted Therapy for Cancer Quick View
    • Cabozanix (Cabozantinib 20,60,80mg):Targeted Therapy for Cancer

    • Cabozanix (Cabozantinib) is a cutting-edge oral medication designed to treat advanced stages of various cancers, including renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), and medullary thyroid cancer (MTC). As a tyrosine kinase inhibitor (TKI), Cabozantinib blocks specific proteins that drive the growth and spread of cancer cells. Available in 20 mg, 60 mg, and 80 mg strengths, Cabozanix is a…
    • Read more
  • Capmaxen-200MG Quick View
    • Capmaxen-200MG Quick View
    • Capmaxen-200MG

    •   Capmaxen-200MG is a highly effective antibiotic designed to tackle many bacterial infections. With its powerful 200MG formulation, this medication is ideal for treating common infections such as respiratory tract infections, urinary tract infections, and skin infections. Capmaxen-200MG works by inhibiting bacterial growth, allowing your immune system to clear the infection and helping you feel better faster.   Whether you’re…
    • Read more
  • Cerinib 150 mg (Ceritinib) Quick View
    • Cerinib 150 mg (Ceritinib) Quick View
    • Cerinib 150 mg (Ceritinib)

    • Cerinib 150 mg contains Ceritinib, a powerful targeted therapy specifically designed for the treatment of ALK-positive non-small cell lung cancer (NSCLC). It is an oral medication used to manage advanced stages of lung cancer, particularly in patients whose cancer has spread to other parts of the body (metastatic) and who may have developed resistance to prior treatments. Ceritinib works by…
    • Read more
  • Crizocent 250mg Quick View
    • Crizocent 250mg Quick View
    • Crizocent 250mg

    • Crizocent 250mg (Crizotinib) is a highly effective targeted therapy specifically designed to treat advanced non-small cell lung cancer (NSCLC) that is ALK-positive (anaplastic lymphoma kinase) or ROS1-positive. This innovative medication works by blocking the activity of proteins (ALK and ROS1) that promote cancer cell growth, making it an essential treatment for patients with these specific genetic mutations. Crizocent is trusted…
    • Read more
  • Elbonix 50mg/25mgElbonix 50mg/25mg Quick View
    • Elbonix 50mg/25mgElbonix 50mg/25mg Quick View
    • Elbonix 50mg/25mg

    • Elbonix-50mg/25mg is a widely prescribed pharmaceutical formulation designed to treat specific medical conditions effectively. Known for its dual-action composition, Elbonix combines two active ingredients, each contributing to its therapeutic efficacy. In this blog post, we’ll delve into the details of Elbonix-50mg/25mg, including its indications, pharmacology, dosage, interactions, side effects, precautions, and more. Whether you’re a healthcare professional or a patient…
    • Read more
  • Elopag 25mg & 50mg Quick View
    • Elopag 25mg & 50mg Quick View
    • ,
    • Elopag 25mg & 50mg

    • Elopag 25mg & 50mg, powered by the active ingredient Eltrombopag, is a highly effective oral medication used to treat chronic immune thrombocytopenia (ITP), aplastic anemia, and chronic hepatitis C-related thrombocytopenia. Thrombocytopenia occurs when your platelet count is too low, leading to excessive bruising or bleeding. Elopag works by increasing platelet production, helping to restore a safe platelet level in the…
    • Read more
  • Hernix 40mg (Neratinib) Quick View
    • Hernix 40mg (Neratinib) Quick View
    • Hernix 40mg (Neratinib)

    • Hernix 40 mg, containing the active ingredientNeratinib, is a groundbreaking oral medication specifically designed for patients withearly-stage Targeted therapy for her2-positive breast cancer. It reduces the risk of cancer recurrence after initial treatments such as surgery or chemotherapy. As a tyrosine kinase inhibitor (TKI), Hernix targets and blocks specific proteins involved in cancer cell growth, helping prevent the spread and…
    • Read more
  • Hertinib-40mg (Neratinib): HER2 Positive Breast Cancer Quick View
    • Hertinib-40mg (Neratinib): HER2 Positive Breast Cancer Quick View
    • ,
    • Hertinib-40mg (Neratinib): HER2 Positive Breast Cancer

    • Hertinib-40mg (Neratinib) is an advanced oral medication specifically designed to treat early-stage HER2-positive breast cancer in patients who have completed prior trastuzumab-based therapy. As a targeted therapy, Hertinib-40mg works by inhibiting the HER2 protein, which is responsible for the growth and spread of cancer cells. By blocking this protein, Hertinib-40mg helps prevent cancer from returning, offering patients improved outcomes and…
    • Read more
  • Ibrucent 140 mg (Ibrutinib) Quick View
    • Ibrucent 140 mg (Ibrutinib) Quick View
    • ,
    • Ibrucent 140 mg (Ibrutinib)

    • Ibrucent 140 mg (Ibrutinib) is an innovative oral medication used to treat specific types of blood cancers, including Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma (MCL), and Waldenström’s Macroglobulinemia (WM). Ibrutinib, the active ingredient in Ibrucent, is a Bruton’s Tyrosine Kinase (BTK) inhibitor. This targeted therapy blocks the activity of BTK proteins, which are crucial for the growth and survival…
    • Read more
  • Ibrutix 140mg (Ibrutinib): Blood Cancer Therapy Quick View
    • Ibrutix 140mg (Ibrutinib): Blood Cancer Therapy Quick View
    • Ibrutix 140mg (Ibrutinib): Blood Cancer Therapy

    • Ibrutix 140mg (Ibrutinib) is a breakthrough oral medication used for the treatment of specific blood cancers such as Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma (MCL), and Waldenström's Macroglobulinemia (WM). Ibrutinib, the active ingredient in Ibrutix, is a targeted therapy that works by inhibiting Bruton's Tyrosine Kinase (BTK), a protein essential for the growth and survival of cancerous B-cells. By…
    • Read more